$4.930
-0.088 (-1.79%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CSBR Prediction & Forecast by Similar Chart Analysis
Alphio's CSBR stock price prediction model matches the current Champions Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.90 (-0.56%). The 1-week path is $4.97 (+0.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Champions Oncology Inc Stock?
CSBR is not a strong buy at the moment due to its current price of $4.93, which is significantly lower than its 200-day moving average of $6.13, indicating a bearish trend. The RSI is at 40.16, suggesting the stock is nearing oversold territory but not yet a clear buy signal. Additionally, the forward P/E ratio of 22.88 indicates that the stock may be overvalued based on future earnings expectations. The main risk is the declining net income, with a reported net income of -667,000 USD in Q4 2026, reflecting ongoing profitability challenges.
CSBR stock price ended at $4.93 on Friday, after losing -1.79%
Champions Oncology Inc (CSBR) last closed at $4.93, losing -1.79%. These facts feed the 1-day and 1-week CSBR price prediction above.
Analyst Consensus
Champions Oncology Inc (CSBR): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Champions Oncology Inc (CSBR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CSBR, ranked by similarity.
Seasonality analysis for CSBR
Historically the probability of a positive August return for CSBR is 0.00%. January offers the highest probability of a positive month at 93.44%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CSBR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $5.98 | $6.99 | $7.80 | +41.71% |
| Sep 2026 | $4.94 | $6.39 | $6.64 | +29.56% |
| Oct 2026 | $5.95 | $7.20 | $7.64 | +46.10% |
| Nov 2026 | $8.15 | $8.46 | $9.50 | +71.57% |
| Dec 2026 | $6.97 | $7.86 | $7.89 | +59.41% |
In 2026, Champions Oncology Inc (CSBR) is projected to range from $4.94 to $9.50.
Champions Oncology Inc 2026 monthly forecast
In Aug 2026, Champions Oncology Inc is projected to average $6.99, with a low of $5.98 and high of $7.80.
In Sep 2026, Champions Oncology Inc is projected to average $6.39, with a low of $4.94 and high of $6.64.
In Oct 2026, Champions Oncology Inc is projected to average $7.20, with a low of $5.95 and high of $7.64.
In Nov 2026, Champions Oncology Inc is projected to average $8.46, with a low of $8.15 and high of $9.50.
In Dec 2026, Champions Oncology Inc is projected to average $7.86, with a low of $6.97 and high of $7.89.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.